Artiva Biotherapeutics (ARTV)'s 30-day implied volatility (IV30) was 64.5% at the close on November 3, 2026, down from 72.9% the day before, against a 52-week range of 67.8% to 107.1%. Its 20-day historical volatility was 81.3%.
Data as of November 3, 2026.